Gus Lawlor

Chief Operating Officer at Leap Therapeutics, Inc.

Gus Lawlor

Gus Lawlor

Chief Operating Officer at Leap Therapeutics, Inc.

Overview
Career Highlights

Leap Therapeutics, Inc.
LeukoSite, Inc.
BioSurface Technology, Inc.

RelSci Relationships

935

Number of Boards

30

Birthday

1957

Age

62

Contact Data
Trying to get in touch with Gus Lawlor? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Gus Lawlor likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer at Leap Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Leap Therapeutics, Inc.

Relationship likelihood: Strong

President at HealthCare Ventures LLC

Relationship likelihood: Strong

Co-Founder at HealthCare Ventures LLC

Relationship likelihood: Strong

General Partner at HealthCare Ventures LLC

Relationship likelihood: Strong

Former Partner, Life Sciences at Morgenthaler Management Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at Catalyst Biosciences, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Faraday Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder at Mosaic Biosciences, Inc.

Relationship likelihood: Strong

Treasurer & Director at GITR, Inc.

Relationship likelihood: Strong

Paths to Gus Lawlor
Potential Connections via
Relationship Science
You
Gus Lawlor
Chief Operating Officer at Leap Therapeutics, Inc.
Education
Master's in Public & Private Management

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

B.A.

UNH is a vibrant place: a land-, sea-, and space-grant university located in Durham, N.H., Concord, N.H. and Manchester, NH.

MBA

The Yale School of Management is the graduate business school of Yale University and is located on Hillhouse Avenue in New Haven, Connecticut, United States. The School awards the Master of Business Administration (MBA), Master of Advanced Management (MAM), and Ph.D. degrees. As of April 2012, 475 students were enrolled in its MBA program, 33 in the MBA for Executives program, and 33 in the PhD program.

Career History
Chief Operating Officer
2015 - Current

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01 and TRX518. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Managing Director
2000 - Current

Healthcare Ventures (HCV) invests in pre-clinical or early clinical stage, project-focused companies with the potential to transform patient care. The firm seeks to identify high potential products within academia or pharmaceutical companies and develop them into clinical proof-of-concept within capital efficient, semi-virtual organizations. They seek to generate superior returns through acquisitions by pharmaceutical and biotechnology companies. HCV invests in early-stage and emerging growth healthcare companies that have the potential for exceptional growth. The firm invests primarily in privately-owned companies. They target companies that are well-positioned to grow rapidly in value based on product development timelines, capital requirements and future demand for products. The companies HCV invests in support a broad array of technology platforms and offer late-stage products or novel innovations. The firm also looks for companies that can retain their product rights and have near-term potential cash flow. HCV expects liquidity in 3 to 5 years at a valuation in excess of 10 times invested capital. Companies should have revenues that minimize equity capital requirements and technology platforms that generate multiple products.

Managing Director
Current
Boards & Committees
Director
Prior - 2009

Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA.

Chairman, Compensation Committee
2004 - 2012

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Political Donations
$2,500
2012

Former Governor of Wisconsin

$1,000
2000
Transactions
Details Hidden

Leap Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

GITR, Inc. raised money in a private placement transaction

Details Hidden

GITR, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gus Lawlor. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gus Lawlor's profile does not indicate a business or promotional relationship of any kind between RelSci and Gus Lawlor.